Advertisement
Screener

Anika Therapeutics, Inc. (ANIK) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

1.8 / 5 stars · 44/120 Roast Me

Anika Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities

Anika Therapeutics, Inc. (ANIK) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 738.69 thousand shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-13.

Discontinued › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2014-03-13

  • Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2013 was 738.69K shares, a 31.85% decline from fiscal 2012.
  • Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2012 was 1.08M shares, a 58.51% increase from fiscal 2011.
  • Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2011 was 683.76K shares.
Period endIncremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month
2013-12-31738.69K shares
10-K · filed 2014-03-13
2012-12-311.08M shares
10-K · filed 2014-03-13
2011-12-31683.76K shares
10-K · filed 2014-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25